These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 21162619)
1. One does not fit all: new adjuvants are needed and vaccine formulation is critical. Korsholm KS Expert Rev Vaccines; 2011 Jan; 10(1):45-8. PubMed ID: 21162619 [TBL] [Abstract][Full Text] [Related]
2. Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland. Fox CB Hum Vaccin Immunother; 2013 Sep; 9(9):2007-8. PubMed ID: 23787558 [TBL] [Abstract][Full Text] [Related]
3. Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland. Collin N Hum Vaccin Immunother; 2013 Sep; 9(9):2015-6. PubMed ID: 23966098 [TBL] [Abstract][Full Text] [Related]
5. Fourth International Conference: Modern Vaccines/Adjuvants Formulation--Impact on Future Development: May 15-17 2013, CHUV, Lausanne, Switzerland. Tupin E Hum Vaccin Immunother; 2013 Sep; 9(9):2009-12. PubMed ID: 23896583 [TBL] [Abstract][Full Text] [Related]
6. Are we entering a new age for human vaccine adjuvants? O'Hagan DT; Fox CB Expert Rev Vaccines; 2015 Jul; 14(7):909-11. PubMed ID: 25947042 [TBL] [Abstract][Full Text] [Related]
7. Current adjuvants and new perspectives in vaccine formulation. Montomoli E; Piccirella S; Khadang B; Mennitto E; Camerini R; De Rosa A Expert Rev Vaccines; 2011 Jul; 10(7):1053-61. PubMed ID: 21806399 [TBL] [Abstract][Full Text] [Related]
8. Adjuvants for veterinary vaccines--types and modes of action. Gerdts V Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):456-63. PubMed ID: 26697712 [TBL] [Abstract][Full Text] [Related]
9. New generation adjuvants--from empiricism to rational design. O'Hagan DT; Fox CB Vaccine; 2015 Jun; 33 Suppl 2():B14-20. PubMed ID: 26022561 [TBL] [Abstract][Full Text] [Related]
10. Combination adjuvants: the next generation of adjuvants? Mutwiri G; Gerdts V; van Drunen Littel-van den Hurk S; Auray G; Eng N; Garlapati S; Babiuk LA; Potter A Expert Rev Vaccines; 2011 Jan; 10(1):95-107. PubMed ID: 21162624 [TBL] [Abstract][Full Text] [Related]
11. Carbohydrate-based vaccine adjuvants - discovery and development. Hu J; Qiu L; Wang X; Zou X; Lu M; Yin J Expert Opin Drug Discov; 2015 Oct; 10(10):1133-44. PubMed ID: 26372693 [TBL] [Abstract][Full Text] [Related]
12. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators. Chauhan N; Tiwari S; Iype T; Jain U Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554 [TBL] [Abstract][Full Text] [Related]
13. Communicating the role and value of vaccine adjuvants. Gellin BG; Salisbury DM Vaccine; 2015 Jun; 33 Suppl 2():B44-6. PubMed ID: 26022567 [TBL] [Abstract][Full Text] [Related]
14. The perfect mix: recent progress in adjuvant research. Guy B Nat Rev Microbiol; 2007 Jul; 5(7):505-17. PubMed ID: 17558426 [TBL] [Abstract][Full Text] [Related]
16. When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes. Exley C Vaccine; 2012 Mar; 30(12):2042. PubMed ID: 22041301 [No Abstract] [Full Text] [Related]
17. Lipid and carbohydrate based adjuvant/carriers in immunology. McGeary RP; Olive C; Toth I J Pept Sci; 2003 Jul; 9(7):405-18. PubMed ID: 12916638 [TBL] [Abstract][Full Text] [Related]
18. Unmet needs in modern vaccinology: adjuvants to improve the immune response. Leroux-Roels G Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254 [TBL] [Abstract][Full Text] [Related]